BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 877647)

  • 1. Testing for the Tay-Sachs gene in the Atlanta Jewish population.
    Marion JP; Danner DJ; Ballou WR; Marion R; Elsas LJ
    South Med J; 1977 Jul; 70(7):833-7. PubMed ID: 877647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tay-Sachs disease: a pilot screening program for the detection of the heterozygote in the Charleston Jewish community.
    Rogers JF; Hogan EL; Jorgenson RJ
    South Med J; 1976 Nov; 69(11):1453-5. PubMed ID: 1019641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approaches to the control and prevention of Tay-Sachs disease.
    Kaback MM; Zeiger RS; Reynolds LW; Sonneborn M
    Prog Med Genet; 1974; 10():103-34. PubMed ID: 4620174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: the first 1000 cases at New York University Medical Center, New York, NY.
    Kronn D; Jansen V; Ostrer H
    Arch Intern Med; 1998 Apr; 158(7):777-81. PubMed ID: 9554684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for carriers of Tay-Sachs disease among Ashkenazi Jews. A comparison of DNA-based and enzyme-based tests.
    Triggs-Raine BL; Feigenbaum AS; Natowicz M; Skomorowski MA; Schuster SM; Clarke JT; Mahuran DJ; Kolodny EH; Gravel RA
    N Engl J Med; 1990 Jul; 323(1):6-12. PubMed ID: 2355960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for carriers of Tay-Sachs disease: A community project.
    Lowden JA; Zuker S; Wilensky AJ; Skomorowski MA
    Can Med Assoc J; 1974 Aug; 111(3):229-33. PubMed ID: 4854206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A screening program for Tay-Sachs disease in Israel.
    Padeh B
    Isr J Med Sci; 1973; 9(9):1330-4. PubMed ID: 4775113
    [No Abstract]   [Full Text] [Related]  

  • 8. Automated determination of serum hexosaminidase A by pH inactivation for detection of Tay-Sachs disease heterozygotes.
    Saifer A; Perle G
    Clin Chem; 1974 May; 20(5):538-43. PubMed ID: 4826945
    [No Abstract]   [Full Text] [Related]  

  • 9. Community screening for Tay-Sachs disease.
    Jackson LG; Nimoityn P; Faust HS; Glazerman LR
    Am Fam Physician; 1976 Apr; 13(4):111-4. PubMed ID: 1266700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human hexosaminidase isozymes: chromatographic separation as an aid to heterozygote identification.
    Nakagawa S; Kumin S; Nitowsky HM
    Clin Chim Acta; 1977 Mar; 75(2):181-91. PubMed ID: 851488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tay-Sachs disease in a Moroccan Jewish family: a possible new mutation.
    Bach G; Navon R; Zeigler M; Beyth Y; Porter B; Cohen MM
    Isr J Med Sci; 1976 Dec; 12(12):1432-9. PubMed ID: 1017941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carrier detection in Sandhoff disease.
    Lowden JA; Ives EJ; Keene DL; Burton AL; Skomorowski MA; Howard F
    Am J Hum Genet; 1978 Jan; 30(1):38-45. PubMed ID: 414620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tay-Sachs carrier detection by mechanized serum hexosaminidase assay.
    Rosenberg D; Cutler R
    Clin Chim Acta; 1974 Jun; 53(2):247-53. PubMed ID: 4841990
    [No Abstract]   [Full Text] [Related]  

  • 14. Segregation within a family of two mutant alleles for hexosaminidase A.
    Kelly TE; Reynolds LW; O'Brien JS
    Clin Genet; 1976 May; 9(5):540-3. PubMed ID: 1269177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A molecular variant of Tay-Sachs disease in a non-Ashkenazi Jewish family.
    Bach G; Cohen MM
    Prog Clin Biol Res; 1977; 18():189-94. PubMed ID: 601076
    [No Abstract]   [Full Text] [Related]  

  • 16. Population-based Tay-Sachs screening among Ashkenazi Jewish young adults in the 21st century: Hexosaminidase A enzyme assay is essential for accurate testing.
    Schneider A; Nakagawa S; Keep R; Dorsainville D; Charrow J; Aleck K; Hoffman J; Minkoff S; Finegold D; Sun W; Spencer A; Lebow J; Zhan J; Apfelroth S; Schreiber-Agus N; Gross S
    Am J Med Genet A; 2009 Nov; 149A(11):2444-7. PubMed ID: 19876898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tay-Sachs disease screening and prevention in South Africa.
    Jenkins T; Lane AB; Kromberg JG
    S Afr Med J; 1977 Jan; 51(4):95-8. PubMed ID: 841439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population-specific screening by mutation analysis for diseases frequent in Ashkenazi Jews.
    DeMarchi JM; Caskey CT; Richards CS
    Hum Mutat; 1996; 8(2):116-25. PubMed ID: 8844209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Tay-Sachs by hexosaminidase analysis of urine and tear samples.
    Saifer A; Amoroso J; Perle G
    Adv Exp Med Biol; 1976; 68():339-66. PubMed ID: 7107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated frequency of Tay-Sachs disease among Ashkenazic Jews unlikely by genetic drift alone.
    Chakravarti A; Chakraborty R
    Am J Hum Genet; 1978 May; 30(3):256-61. PubMed ID: 677122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.